THC Beverage Regulation: State Laws, Compliance & Industry Standards

Executive Summary

THC-infused beverages occupy a regulatory gray zone across the United States, with products frequently sold alongside conventional soft drinks in violation of state cannabis laws. As of July 2026, the cannabis beverage market represents a $1.2 billion segment of the broader legal cannabis industry, yet enforcement of placement, packaging, and potency regulations remains inconsistent. Hemp-derived delta-8 THC and delta-9 THC beverages exploit loopholes in the 2018 Farm Bill, appearing in gas stations and convenience stores in states where adult-use cannabis remains illegal. Meanwhile, state-licensed cannabis beverages face strict child-resistant packaging requirements, dosage caps typically at 5-10 mg THC per serving, and mandatory separation from non-intoxicating products—rules routinely violated at retail. The regulatory patchwork creates consumer confusion, undermines public health safeguards designed to prevent youth access, and places compliant operators at a competitive disadvantage. Federal agencies including the FDA and DEA have issued limited guidance, leaving states to navigate enforcement independently while the industry grows at a compound annual rate exceeding 30 percent.

Why THC Beverage Regulation Matters

The stakes involve public health, market fairness, tax revenue integrity, and the credibility of state cannabis regulatory frameworks. Approximately 38 states have legalized cannabis in some form as of 2026, with 24 permitting adult-use sales. Cannabis beverages appeal to health-conscious consumers seeking smoke-free consumption and precise dosing, but improper retail placement exposes minors to products that can be mistaken for conventional drinks. A 2025 survey by the Cannabis Regulators Association found that 43 percent of licensed retailers in adult-use states reported observing THC beverages sold outside designated cannabis areas, often near energy drinks or flavored waters. For operators, regulatory compliance determines market access. Multi-state operators including Curaleaf, Cresco Labs, and Green Thumb Industries have invested heavily in beverage production facilities, banking on beverages to drive category growth as flower sales plateau. Beverage products command wholesale prices of $4-8 per unit compared to $2-4 for equivalent edibles, offering superior margins. Yet unlicensed hemp-derived THC beverages—sold without the overhead of seed-to-sale tracking, laboratory testing, or excise taxes—undercut licensed products by 40-60 percent on price. Patients relying on medical cannabis beverages for consistent dosing face quality and safety risks when purchasing from unregulated channels. State tax authorities lose revenue when sales migrate to untaxed hemp products. Municipalities enforcing zoning restrictions on cannabis retailers confront enforcement challenges when convenience stores stock intoxicating beverages derived from hemp. The regulatory chaos threatens the social equity goals embedded in legalization statutes, as well-capitalized hemp beverage companies bypass licensing requirements designed to remediate past enforcement harms.

Background and History: The Evolution of Cannabis Beverage Regulation

Cannabis beverages emerged as a distinct product category following Colorado's launch of adult-use sales in January 2014, though regulatory frameworks lagged product innovation by years.

2014-2016: Early Market Experimentation

Colorado's Marijuana Enforcement Division initially treated beverages identically to edibles under the Colorado Retail Marijuana Code. Early entrants including Dixie Elixirs and Keef Brands launched THC-infused sodas and fruit punches, packaged in bottles resembling conventional beverages. By December 2015, Colorado regulators documented 37 incidents of accidental pediatric ingestion involving cannabis beverages, prompting emergency rulemaking. The state imposed opaque, child-resistant packaging requirements and mandated that beverages be divided into 10 mg servings with physical separation or clear demarcation—rules that became the template for other states. Washington state, which launched adult-use sales in July 2014, initially capped edible and beverage potency at 10 mg THC per package. The Washington State Liquor and Cannabis Board amended rules in 2016 to allow multi-serving packages up to 100 mg, provided each serving was individually wrapped or the product included a measuring device. California's Bureau of Cannabis Control, preparing for January 2018 adult-use launch, studied both states' frameworks.

2018: The Farm Bill Loophole Opens

The Agriculture Improvement Act of 2018, signed December 20, 2018, removed hemp—defined as cannabis with less than 0.3 percent delta-9 THC by dry weight—from Schedule I of the Controlled Substances Act. The law, codified at 7 U.S.C. § 1639o, legalized hemp cultivation and authorized interstate commerce in hemp-derived products. Congress intended to support fiber and CBD industries, but the statute's silence on intoxicating hemp-derived cannabinoids created an unintended pathway for delta-8 THC, delta-10 THC, THC-O, and hemp-derived delta-9 THC products. Entrepreneurs recognized that a beverage containing 10 mg of delta-9 THC derived from hemp, if the total product weight exceeded 3,333 grams (approximately one gallon), would meet the 0.3 percent threshold. By late 2019, hemp-derived delta-9 beverages appeared in Texas, Florida, and other non-legal states, marketed as "federally compliant" and sold without age restrictions in some jurisdictions.

2020-2022: State Responses Diverge

The COVID-19 pandemic accelerated cannabis beverage adoption as consumers sought alternatives to smoking. Nielsen reported that cannabis beverage sales in tracked dispensaries grew 78 percent in 2021, outpacing all other categories. States responded to the hemp loophole inconsistently: Colorado amended its hemp regulations in March 2021 to cap total THC in hemp products at 5 mg per package, effectively banning intoxicating hemp beverages. California's Assembly Bill 45, effective January 2023, prohibited hemp-derived intoxicating cannabinoids in food and beverages, directing enforcement to the Department of Public Health. New York's Office of Cannabis Management issued guidance in October 2022 stating that any intoxicating cannabinoid product, regardless of source, required a cannabis license. Conversely, Texas, Florida, Georgia, and Minnesota took no action, allowing hemp-derived THC beverages to proliferate in convenience stores and online. The Minnesota Department of Health estimated in 2022 that hemp-derived edibles and beverages generated $150-200 million in annual sales—revenue entirely outside the state's tax and regulatory system.

2023-2024: Enforcement Gaps Widen

State cannabis regulators, already stretched thin overseeing licensed markets, struggled to enforce beverage-specific rules. A 2023 audit by the Massachusetts Cannabis Control Commission found that 29 percent of sampled retailers displayed cannabis beverages in refrigerated cases alongside non-cannabis products, violating 935 CMR 500.105(2), which requires physical separation. The Commission issued warnings but lacked resources for systematic compliance checks. Industry consolidation brought beverage expertise into cannabis. Constellation Brands' $4 billion investment in Canopy Growth, announced in 2018, funded development of Quatreau, a zero-calorie THC sparkling water launched in Canada in 2020. Tilray acquired multiple beverage brands and brewing facilities, positioning for U.S. market entry upon federal reform. Molson Coors formed a joint venture with HEXO to develop Truss beverages. These companies advocated for clear federal standards, arguing that the regulatory patchwork hindered interstate commerce and brand development.

2025-2026: Crisis of Confidence

By early 2025, the regulatory disconnect reached crisis levels. The FDA issued Warning Letters to 14 hemp beverage manufacturers in March 2025, citing violations of the Federal Food, Drug, and Cosmetic Act for marketing unapproved drugs and making unsubstantiated health claims. The letters targeted delta-8 and THC-O products but did not address hemp-derived delta-9 beverages meeting the 0.3 percent threshold. The DEA, in testimony before the Senate Judiciary Committee in June 2025, stated that it lacked resources to pursue hemp-derived THC products absent clear Congressional direction. State attorneys general from Colorado, Washington, Oregon, and California sent a joint letter to the FDA in September 2025 requesting emergency rulemaking to close the hemp loophole. The FDA responded in December 2025 with an Advance Notice of Proposed Rulemaking (ANPRM) soliciting comments on cannabinoid regulation in food and beverages, with a comment period extending through March 2026. As of July 2026, no proposed rule has been published. The triggering incident—widespread retail violations documented by STAT in July 2026—reflects the culmination of a decade of regulatory drift. Retailers, facing minimal enforcement risk, prioritize sales over compliance. Consumers, unable to distinguish licensed from unlicensed products, make purchasing decisions based on price and availability rather than safety or quality.

Key Players in THC Beverage Regulation

Drug Enforcement Administration (DEA)

The DEA maintains authority over controlled substances under 21 U.S.C. § 812. Cannabis remains a Schedule I substance as of July 2026, though the DEA's Notice of Proposed Rulemaking to reschedule cannabis to Schedule III, published in May 2024, remains pending final action. The agency has stated that hemp-derived delta-8 THC and synthetic cannabinoids fall under its jurisdiction as controlled substance analogues under 21 U.S.C. § 813, but has not pursued enforcement actions against beverage manufacturers. The DEA's focus remains on illicit fentanyl and methamphetamine trafficking.

Food and Drug Administration (FDA)

The FDA regulates food and beverage safety under 21 U.S.C. § 301 et seq. The agency has asserted that adding CBD or THC to food or beverages violates the Federal Food, Drug, and Cosmetic Act because cannabinoids were investigated as drugs before being marketed in food. However, the FDA has not established enforcement priorities for THC beverages, issuing only sporadic Warning Letters. The agency's Center for Food Safety and Applied Nutrition is developing a regulatory framework but faces resource constraints and political pressure from both industry and public health advocates.

State Cannabis Regulatory Agencies

Each state with legal cannabis operates a regulatory body: the California Department of Cannabis Control, the Colorado Marijuana Enforcement Division, the Massachusetts Cannabis Control Commission, and others. These agencies set potency limits, packaging requirements, testing standards, and retail display rules. Enforcement capacity varies widely. California employs approximately 350 inspectors for over 10,000 licensed premises, while smaller states like Vermont operate with fewer than a dozen field staff. Budget constraints and staff turnover hamper consistent enforcement.

Multi-State Operators (MSOs)

Curaleaf, Trulieve, Green Thumb Industries, Cresco Labs, and Verano Holdings have invested in beverage production as a growth vertical. These companies advocate for strict regulation of hemp-derived competitors and federal reform to enable interstate commerce. Curaleaf's Select brand includes a line of nano-emulsified THC beverages with onset times under 15 minutes, marketed as a premium alternative to alcohol. Green Thumb Industries reported in its Q1 2026 earnings call that beverages represented 8 percent of revenue, up from 3 percent in 2023, with gross margins exceeding 60 percent.

Hemp Beverage Manufacturers

Companies including Cann, Recess, and Cycling Frog produce hemp-derived delta-9 THC beverages sold in non-legal states. These firms argue that their products comply with the 2018 Farm Bill and fill consumer demand in markets where state-licensed cannabis is unavailable. They oppose state bans on hemp-derived intoxicants, framing the issue as federal preemption under the Supremacy Clause. Industry trade groups including the U.S. Hemp Roundtable have lobbied against state restrictions.

Public Health Advocates

Organizations including the American Academy of Pediatrics, the Campaign for Tobacco-Free Kids, and Smart Approaches to Marijuana oppose lax beverage regulation, citing risks of youth access and impaired driving. These groups have supported state legislation requiring plain packaging, high excise taxes, and strict retail separation. They argue that the beverage industry's marketing tactics—colorful labels, fruit flavors, and placement near conventional drinks—mirror strategies used by tobacco and alcohol companies to attract young consumers.

Legal and Regulatory Framework

THC beverage regulation operates across three overlapping legal domains: federal controlled substances law, state cannabis statutes, and food safety regulations. At the federal level, the Controlled Substances Act, 21 U.S.C. § 801 et seq., classifies cannabis as Schedule I, prohibiting manufacture, distribution, and possession except for federally approved research. The 2018 Farm Bill, 7 U.S.C. § 1639o, carved out an exception for hemp, defined as cannabis with no more than 0.3 percent delta-9 THC on a dry weight basis. This definition creates the legal basis for hemp-derived THC beverages, though the FDA maintains that adding cannabinoids to food violates 21 U.S.C. § 331(ll) and 21 U.S.C. § 321(ff)(3)(B). State cannabis laws vary significantly. California's Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA), codified at Business and Professions Code § 26000 et seq., caps edible and beverage products at 100 mg THC per package with 10 mg servings. Colorado Revised Statutes § 44-10-101 et seq. imposes similar limits. New York's Cannabis Law, Article 4, limits beverages to 10 mg THC per container for adult-use products. Illinois, under the Cannabis Regulation and Tax Act, 410 ILCS 705, allows 100 mg packages for adult-use consumers but caps medical beverages at 10 mg for certain patient categories. Packaging requirements are near-universal: child-resistant closures meeting 16 C.F.R. § 1700.20, opaque or resealable containers, and warning labels. California requires a universal cannabis symbol, a "THC" designation, and the statement "FOR USE ONLY BY ADULTS 21 YEARS OF AGE AND OLDER. KEEP OUT OF REACH OF CHILDREN." Massachusetts mandates batch and tracking numbers under its seed-to-sale system. Retail display rules aim to prevent confusion with non-intoxicating products. Massachusetts regulations, 935 CMR 500.105, require that cannabis products be stored in a restricted access area separate from any area accessible to the public. Michigan's Marijuana Regulatory Agency mandates that beverages be displayed in a dedicated section with signage indicating "CANNABIS PRODUCTS." Enforcement of these provisions is inconsistent, as documented in the July 2026 STAT report. Taxation structures create additional compliance layers. California imposes a 15 percent excise tax on cannabis retail sales, plus state and local sales taxes. Illinois charges 25 percent excise tax on adult-use products over 35 percent THC, 20 percent on infused products, and 10 percent on flower. Washington applies a 37 percent excise tax. These taxes apply only to state-licensed products, giving untaxed hemp beverages a significant price advantage.

State-by-State Breakdown of THC Beverage Regulation

California

California permits adult-use cannabis beverages under MAUCRSA, with sales beginning January 2018. The Department of Cannabis Control caps beverages at 100 mg THC per package with 10 mg servings. Assembly Bill 45, effective January 2023, prohibits hemp-derived intoxicating cannabinoids in food and beverages, directing enforcement to county health departments. As of June 2026, California had issued 1,247 licensed beverage manufacturing permits, with major production concentrated in Los Angeles, Oakland, and Santa Rosa. Retail violations remain common; a 2025 compliance sweep found violations at 18 percent of sampled retailers.

Colorado

Colorado's Marijuana Enforcement Division regulates beverages under the Colorado Retail Marijuana Code. Potency is capped at 100 mg THC per package for adult-use products, with 10 mg servings. Colorado amended its hemp statute in 2021 to limit hemp products to 5 mg total THC per package, effectively banning intoxicating hemp beverages. The state requires beverages to be stored behind counters or in locked cases. Colorado collected $423 million in cannabis tax revenue in 2025, with beverages representing an estimated 6 percent of total sales.

New York

New York's Office of Cannabis Management limits beverages to 10 mg THC per container for adult-use sales, which began in December 2022. The state prohibits hemp-derived intoxicating products, requiring all cannabinoid beverages to be sold through licensed dispensaries. Enforcement has been hampered by slow licensing; as of July 2026, only 187 adult-use dispensaries were operational statewide, while unlicensed hemp shops number in the thousands. The state has seized hemp-derived THC products in raids but lacks resources for comprehensive enforcement.

Illinois

Illinois allows 100 mg THC beverage packages under 410 ILCS 705, with 10 mg servings. The state's Cannabis Regulation Oversight Officer reported in 2025 that beverages accounted for 4.2 percent of sales by volume but 7.1 percent by revenue, reflecting premium pricing. Illinois prohibits hemp-derived intoxicating products through administrative rule, though enforcement is limited. The state collected $445 million in cannabis tax revenue in fiscal year 2025.

Michigan

Michigan's Marijuana Regulatory Agency permits 100 mg beverage packages with 10 mg servings. The state has not banned hemp-derived THC products, leading to parallel markets. Licensed dispensaries compete with gas stations and smoke shops selling hemp beverages at lower prices. Michigan collected $290 million in cannabis excise taxes in 2025, but officials estimate that hemp product sales represent $100-150 million in untaxed commerce.

Massachusetts

Massachusetts caps beverages at 100 mg THC per package under 935 CMR 500. The Cannabis Control Commission requires beverages to be stored separately from non-cannabis products and prohibits refrigerated display alongside conventional drinks. The 2023 audit finding 29 percent non-compliance led to a renewed enforcement initiative in 2024, but violations persist. Massachusetts collected $238 million in cannabis tax revenue in fiscal year 2025.

Florida

Florida permits medical cannabis beverages under limited circumstances, with the Department of Health approving specific formulations. Adult-use cannabis remains illegal, but hemp-derived delta-9 THC beverages are sold widely in convenience stores and online. The state has not enacted restrictions on hemp-derived intoxicants. A November 2026 ballot initiative to legalize adult-use cannabis includes provisions for beverage regulation.

Texas

Texas prohibits cannabis beverages except for low-THC medical cannabis under the Compassionate Use Program, limited to 1 percent THC. However, hemp-derived delta-9 THC beverages are sold openly, exploiting the state's adoption of the federal hemp definition. The Texas Department of State Health Services has issued no guidance on intoxicating hemp products. Estimates suggest the hemp beverage market in Texas exceeds $200 million annually.

Market and Business Implications

The THC beverage market is projected to reach $2.8 billion by 2028, but regulatory uncertainty threatens both growth and consolidation. For multi-state operators, beverages represent a strategic priority. Curaleaf's beverage revenue grew 340 percent year-over-year in 2025, driven by its Select Squeeze and Select Seltzer lines. The company has invested in nano-emulsification technology to reduce onset time to 10-15 minutes, positioning beverages as a direct alcohol substitute. Cresco Labs' Mindy's brand, featuring chef Mindy Segal's recipes, targets female consumers and commands premium pricing at $8-12 per unit wholesale. Capital markets have responded. Beverage-focused startups including Cann, which raised $27 million in Series A funding in 2021, and Keef Brands, which secured $10 million in 2023, have attracted investment from alcohol industry veterans. Constellation Brands, Molson Coors, and Lagunitas (a Heineken subsidiary) have all entered the space through partnerships or direct investment. Wholesale pricing dynamics reveal market segmentation. Licensed cannabis beverages wholesale at $4-8 per unit depending on potency and branding, with retail markups of 50-100 percent. Hemp-derived beverages wholesale at $2-4 per unit and retail at $5-8, undercutting licensed products while avoiding testing costs (typically $200-400 per batch), excise taxes, and seed-to-sale compliance overhead. This price differential has driven licensed operators to lobby for hemp restrictions. The regulatory divide also affects product innovation. Licensed operators invest in controlled-release formulations, precise dosing, and flavor masking to improve consumer experience. Hemp beverage manufacturers, operating with less oversight, have introduced higher-potency products and novel cannabinoids including THC-P and HHC, which may pose unknown safety risks. For retailers, the compliance burden is significant. Dispensaries must maintain separate inventory systems, train staff on ID verification and product placement, and submit to regular inspections. Convenience stores selling hemp beverages face minimal oversight, creating competitive imbalance. Some licensed retailers have advocated for enforcement actions against non-compliant competitors, with limited success. Tax revenue implications are substantial. California, Colorado, Washington, Illinois, and Massachusetts collectively collected over $1.8 billion in cannabis excise taxes in 2025. If 10 percent of sales migrate to untaxed hemp products—a conservative estimate—states lose $180 million annually. This revenue funds education, public health, and social equity programs mandated by legalization statutes.

What Experts Say

Regulatory experts, industry leaders, and public health officials agree that the current framework is unsustainable, though they diverge on solutions. According to Hilary Bricken, a cannabis attorney with Harris Bricken, the hemp loophole represents "the single greatest threat to state-regulated cannabis markets." Bricken has argued in multiple forums that states must either ban intoxicating hemp products or integrate them into existing cannabis regulatory systems. She noted that federal preemption arguments are weak because the 2018 Farm Bill explicitly preserved state authority to regulate hemp more restrictively than federal law. Dr. Nora Volkow, director of the National Institute on Drug Abuse, testified before Congress in April 2026 that the proliferation of unregulated THC beverages poses public health risks, particularly for adolescents. Volkow cited research showing that THC consumption during brain development is associated with cognitive deficits and increased risk of psychiatric disorders. She called for federal action to establish potency limits and packaging standards. Industry perspectives vary by business model. Aaron Smith, co-founder of the National Cannabis Industry Association, has stated that licensed operators support strict regulation of hemp-derived intoxicants to ensure product safety and market integrity. Smith has advocated for federal legislation clarifying that intoxicating cannabinoids require state cannabis licenses regardless of source material. Conversely, Jonathan Miller, general counsel for the U.S. Hemp Roundtable, has argued that hemp-derived delta-9 THC beverages are legal under the 2018 Farm Bill and that state bans constitute protectionism for licensed cannabis industries. Miller has pointed to consumer demand in non-legal states as evidence that hemp beverages serve a legitimate market. Public health researchers have documented specific concerns. A 2025 study published in JAMA Pediatrics found that 12 percent of adolescents aged 15-17 in states with legal cannabis reported consuming cannabis beverages in the past year, with most unable to distinguish licensed from unlicensed products. The study's lead author, Dr. Sharon Levy of Boston Children's Hospital, emphasized that appealing flavors and packaging similar to conventional beverages increase youth appeal. State regulators have expressed frustration with resource constraints. According to Nicole Elliott, former director of the California Department of Cannabis Control, the agency receives approximately 500 consumer complaints monthly regarding unlicensed sales, including hemp-derived products, but can investigate only a fraction due to staffing limitations. Elliott has called for increased enforcement funding and federal support.

What's Next: Regulatory Scenarios and Decision Points

The trajectory of THC beverage regulation will be determined by federal action, state enforcement capacity, and industry litigation over the next 18-24 months. The FDA's rulemaking process represents the most significant near-term catalyst. The agency's ANPRM comment period closed in March 2026, with over 18,000 submissions. Industry observers expect a Notice of Proposed Rulemaking in late 2026 or early 2027, potentially establishing federal standards for cannabinoid content in food and beverages. Possible outcomes include: (1) a complete prohibition on adding cannabinoids to food and beverages, (2) a framework allowing CBD but prohibiting THC, or (3) a tiered system with potency limits and labeling requirements. Each scenario would trigger legal challenges and require coordination with state authorities. The DEA's cannabis rescheduling process, if finalized, would not directly affect hemp-derived beverages but could influence the broader regulatory landscape. Rescheduling to Schedule III would maintain federal prohibition on non-medical use while potentially easing research restrictions and tax burdens under 26 U.S.C. § 280E. Some analysts predict that rescheduling could prompt Congress to address the hemp loophole through clarifying legislation. State-level developments will continue to diverge. Minnesota enacted legislation in May 2023 creating a regulatory framework for hemp-derived edibles and beverages, capping products at 5 mg THC per serving and 50 mg per package, with sales restricted to adults 21 and older. This model—regulating rather than banning hemp intoxicants—may be adopted by other states seeking to balance consumer access with safety. Conversely, additional states may follow California's approach of prohibiting hemp-derived intoxicants entirely. Litigation is likely. Hemp beverage manufacturers facing state bans may challenge those laws on federal preemption grounds, arguing that the 2018 Farm Bill authorizes interstate commerce in hemp products. States would counter that the Farm Bill's savings clause, 7 U.S.C. § 1639o(a)(2), preserves state authority to impose stricter regulations. Federal courts have not yet ruled on this issue, and circuit splits are possible. Industry consolidation will accelerate. As regulatory clarity emerges, larger operators with compliance infrastructure will acquire smaller manufacturers unable to navigate complex requirements. Alcohol companies may increase cannabis investments, particularly if federal reform enables interstate commerce. Beverage-alcohol distribution networks could be leveraged for cannabis products, dramatically expanding market reach. Consumer education campaigns will be critical. State agencies, public health organizations, and industry groups must collaborate to help consumers distinguish licensed, tested products from unregulated alternatives. Clear labeling standards and public awareness initiatives could reduce accidental consumption and improve market transparency. The calendar for 2026-2027 includes several key decision points: the FDA's proposed rule on cannabinoids in food (expected Q4 2026), the DEA's final rule on cannabis rescheduling (pending), state legislative sessions in early 2027 where hemp regulation will be debated, and potential Congressional action on cannabis reform if political conditions align. Each of these events will shape the regulatory environment for THC beverages.

Further Reading and Primary Sources

• Agriculture Improvement Act of 2018 (Farm Bill), Public Law 115-334, 7 U.S.C. § 1639o — https://www.congress.gov/bill/115th-congress/house-bill/2
• Controlled Substances Act, 21 U.S.C. § 801 et seq. — https://www.deadiversion.usdoj.gov/21cfr/21usc/
• Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq. — https://www.fda.gov/regulatory-information/laws-enforced-fda/federal-food-drug-and-cosmetic-act-fdc-act
• California Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA), Business and Professions Code § 26000 et seq. — https://leginfo.legislature.ca.gov/faces/codes_displayexpandedbranch.xhtml?tocCode=BPC&division=10
• Colorado Retail Marijuana Code, Colorado Revised Statutes § 44-10-101 et seq. — https://leg.colorado.gov/sites/default/files/images/olls/crs2019-title-44.pdf
• Massachusetts Cannabis Control Commission Regulations, 935 CMR 500 — https://www.mass.gov/regulations/935-CMR-500-adult-use-of-marijuana
• FDA Warning Letters on Cannabis Products — https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd
• Cannabis Regulators Association, "State of the States" Annual Report (2025) — https://www.cannabisregulators.org
• National Institute on Drug Abuse, "Cannabis (Marijuana) Research Report" — https://nida.nih.gov/publications/research-reports/marijuana/letter-director
• U.S. Hemp Roundtable, Policy Positions and Advocacy Updates — https://www.hempsupporter.com
• JAMA Pediatrics, "Adolescent Cannabis Beverage Consumption in Legal Markets" (2025) — https://jamanetwork.com/journals/jamapediatrics
• Curaleaf Holdings Q1 2026 Earnings Report — https://ir.curaleaf.com
• Illinois Cannabis Regulation Oversight Officer Annual Report (2025) — https://www2.illinois.gov/sites/cannabis